Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iradimed (IRMD) Income towards Parent Company (2016 - 2025)

Iradimed (IRMD) has disclosed Income towards Parent Company for 13 consecutive years, with $9.2 million as the latest value for Q4 2025.

  • Quarterly Income towards Parent Company rose 146.33% to $9.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.2 million through Dec 2025, up 542.07% year-over-year, with the annual reading at $25.2 million for FY2025, 542.07% up from the prior year.
  • Income towards Parent Company for Q4 2025 was $9.2 million at Iradimed, up from $5.6 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $9.2 million in Q4 2025, with the low at -$19.8 million in Q4 2024.
  • Average Income towards Parent Company over 5 years is $3.0 million, with a median of $4.2 million recorded in 2023.
  • The sharpest move saw Income towards Parent Company soared 327.39% in 2021, then tumbled 535.92% in 2024.
  • Over 5 years, Income towards Parent Company stood at $4.4 million in 2021, then dropped by 16.27% to $3.7 million in 2022, then grew by 23.58% to $4.5 million in 2023, then crashed by 535.92% to -$19.8 million in 2024, then soared by 146.33% to $9.2 million in 2025.
  • According to Business Quant data, Income towards Parent Company over the past three periods came in at $9.2 million, $5.6 million, and $5.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.